Cargando…

Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system

Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient‐reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashida, Tetsu, Nagayama, Aiko, Seki, Tomoko, Takahashi, Maiko, Matsumoto, Akiko, Kubota, Anna, Jinno, Hiromitsu, Miyata, Hiroaki, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128183/
https://www.ncbi.nlm.nih.gov/pubmed/35279907
http://dx.doi.org/10.1111/cas.15329
_version_ 1784712510376509440
author Hayashida, Tetsu
Nagayama, Aiko
Seki, Tomoko
Takahashi, Maiko
Matsumoto, Akiko
Kubota, Anna
Jinno, Hiromitsu
Miyata, Hiroaki
Kitagawa, Yuko
author_facet Hayashida, Tetsu
Nagayama, Aiko
Seki, Tomoko
Takahashi, Maiko
Matsumoto, Akiko
Kubota, Anna
Jinno, Hiromitsu
Miyata, Hiroaki
Kitagawa, Yuko
author_sort Hayashida, Tetsu
collection PubMed
description Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient‐reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service applications in Japan. In this study, one or more predefined PRO questions for each breast cancer patient's clinical situation were sent to the patient’s LINE application daily. The patient selected a predefined answer by tapping the screen, but no free‐text answers were allowed. Seventy‐three patients were enrolled. The median observation period was 435 days (84‐656 days), and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Patients on adjuvant endocrine therapy were notified of 2.5 questions per week, and the median number of responses per week and response rate were 2.387 (1.687‐11.627) and 95.5%, respectively. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. It was also possible to track each patient’s PROs accurately. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting electronic PROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly.
format Online
Article
Text
id pubmed-9128183
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91281832022-05-25 Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system Hayashida, Tetsu Nagayama, Aiko Seki, Tomoko Takahashi, Maiko Matsumoto, Akiko Kubota, Anna Jinno, Hiromitsu Miyata, Hiroaki Kitagawa, Yuko Cancer Sci ORIGINAL ARTICLES Due to the increasing complexity of cancer treatment, ensuring safety and maintaining the quality of life during treatment are important issues. Patient‐reported outcomes (PROs) in oncology are essential for assessing patient symptoms. A feasibility study was undertaken on breast cancer patients by building a PRO data collection system based on LINE, one of the most popular social network service applications in Japan. In this study, one or more predefined PRO questions for each breast cancer patient's clinical situation were sent to the patient’s LINE application daily. The patient selected a predefined answer by tapping the screen, but no free‐text answers were allowed. Seventy‐three patients were enrolled. The median observation period was 435 days (84‐656 days), and the total number of PROs collected was 16,417, with a mean of 224.9 reports per patient. Patients on adjuvant endocrine therapy were notified of 2.5 questions per week, and the median number of responses per week and response rate were 2.387 (1.687‐11.627) and 95.5%, respectively. Analyzing the results by age group, the number of responses from those aged 60 and above was equal to or higher than that of the younger age group. It was also possible to track each patient’s PROs accurately. These results suggested that the design of the system, based on an application used daily, instead of using specifically prepared applications for collecting electronic PROs, was the reason for the favorable acceptance from patients and the satisfactory response rate from all age groups, including the elderly. John Wiley and Sons Inc. 2022-03-26 2022-05 /pmc/articles/PMC9128183/ /pubmed/35279907 http://dx.doi.org/10.1111/cas.15329 Text en © 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle ORIGINAL ARTICLES
Hayashida, Tetsu
Nagayama, Aiko
Seki, Tomoko
Takahashi, Maiko
Matsumoto, Akiko
Kubota, Anna
Jinno, Hiromitsu
Miyata, Hiroaki
Kitagawa, Yuko
Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
title Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
title_full Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
title_fullStr Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
title_full_unstemmed Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
title_short Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
title_sort feasibility study on collecting patient‐reported outcomes from breast cancer patients using the line‐epro system
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128183/
https://www.ncbi.nlm.nih.gov/pubmed/35279907
http://dx.doi.org/10.1111/cas.15329
work_keys_str_mv AT hayashidatetsu feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT nagayamaaiko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT sekitomoko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT takahashimaiko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT matsumotoakiko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT kubotaanna feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT jinnohiromitsu feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT miyatahiroaki feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem
AT kitagawayuko feasibilitystudyoncollectingpatientreportedoutcomesfrombreastcancerpatientsusingthelineeprosystem